Dea Shahinas ^UDM

Dea Shahinas, the CEO and Co-founder of Deep Biologics Inc., is a seasoned Senior Research Scientist with a strong background in computational biology, drug development, and biologics. With a proven track record in team management and collaboration projects, Dea brings a wealth of expertise in computational biology, structural proteomics, antibody development, and scientific regulatory affairs. Her core strengths include database building, bioinformatics pipelines, critical analysis, and effective communication skills. Dea's qualifications encompass a wide range of experiences, from team building for novel target discovery to identifying high-affinity antibodies and translating developed models into pre-clinical settings. She has excelled in assay development, protein structure solving, transcriptome analysis, and more. At Deep Biologics, Dea leads a mission to revolutionize biologics development using AI and computational analysis, guiding product design for clinic-ready diagnostic and therapeutic solutions. The company combines cutting-edge in silico technologies with conventional screening, offering unprecedented depth, quality, and speed in biologics discovery pipelines. Dea Shahinas's multidimensional skills and expertise contribute significantly to advancing the field of biologics with innovation and efficiency.